Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy

Amreddy Narsireddy,1 Kurra Vijayashree,2 Mahesh G Adimoolam,1 Sunkara V Manorama,1 Nalam M Rao21CSIR – Indian Institute of Chemical Technology, 2CSIR – Centre for Cellular and Molecular Biology, Hyderabad, IndiaAbstract: Challenges in photodynamic therapy (PDT) include developmen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Narsireddy A, Vijayashree K, Adimoolam MG, Manorama SV, Rao NM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/f3efce58317340ebae7f1a0a3945b41e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f3efce58317340ebae7f1a0a3945b41e
record_format dspace
spelling oai:doaj.org-article:f3efce58317340ebae7f1a0a3945b41e2021-12-02T01:08:05ZPhotosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy1178-2013https://doaj.org/article/f3efce58317340ebae7f1a0a3945b41e2015-11-01T00:00:00Zhttps://www.dovepress.com/photosensitizer-and-peptide-conjugated-pamam-dendrimer-for-targeted-in-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Amreddy Narsireddy,1 Kurra Vijayashree,2 Mahesh G Adimoolam,1 Sunkara V Manorama,1 Nalam M Rao21CSIR – Indian Institute of Chemical Technology, 2CSIR – Centre for Cellular and Molecular Biology, Hyderabad, IndiaAbstract: Challenges in photodynamic therapy (PDT) include development of efficient near infrared-sensitive photosensitizers (5,10,15,20-tetrakis(4-hydroxyphenyl)-21H,23H-porphine [PS]) and targeted delivery of PS to the tumor tissue. In this study, a dual functional dendrimer was synthesized for targeted PDT. For targeting, a poly(amidoamine) dendrimer (G4) was conjugated with a PS and a nitrilotriacetic acid (NTA) group. A peptide specific to human epidermal growth factor 2 was expressed in Escherichia coli with a His-tag and was specifically bound to the NTA group on the dendrimer. Reaction conditions were optimized to result in dendrimers with PS and the NTA at a fractional occupancy of 50% and 15%, respectively. The dendrimers were characterized by nuclear magnetic resonance, matrix-assisted laser desorption/ionization, absorbance, and fluorescence spectroscopy. Using PS fluorescence, cell uptake of these particles was confirmed by confocal microscopy and fluorescence-activated cell sorting. PS-dendrimers are more efficient than free PS in PDT-mediated cell death assays in HER2 positive cells, SK-OV-3. Similar effects were absent in HER2 negative cell line, MCF-7. Compared to free PS, the PS-dendrimers have shown significant tumor suppression in a xenograft animal tumor model. Conjugation of a PS with dendrimers and with a targeting agent has enhanced photodynamic therapeutic effects of the PS.Keywords: photodynamic therapy, dendrimers, nanoparticle, targeted delivery, Affibody, xenograft animal modelNarsireddy AVijayashree KAdimoolam MGManorama SVRao NMDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 6865-6878 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Narsireddy A
Vijayashree K
Adimoolam MG
Manorama SV
Rao NM
Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
description Amreddy Narsireddy,1 Kurra Vijayashree,2 Mahesh G Adimoolam,1 Sunkara V Manorama,1 Nalam M Rao21CSIR – Indian Institute of Chemical Technology, 2CSIR – Centre for Cellular and Molecular Biology, Hyderabad, IndiaAbstract: Challenges in photodynamic therapy (PDT) include development of efficient near infrared-sensitive photosensitizers (5,10,15,20-tetrakis(4-hydroxyphenyl)-21H,23H-porphine [PS]) and targeted delivery of PS to the tumor tissue. In this study, a dual functional dendrimer was synthesized for targeted PDT. For targeting, a poly(amidoamine) dendrimer (G4) was conjugated with a PS and a nitrilotriacetic acid (NTA) group. A peptide specific to human epidermal growth factor 2 was expressed in Escherichia coli with a His-tag and was specifically bound to the NTA group on the dendrimer. Reaction conditions were optimized to result in dendrimers with PS and the NTA at a fractional occupancy of 50% and 15%, respectively. The dendrimers were characterized by nuclear magnetic resonance, matrix-assisted laser desorption/ionization, absorbance, and fluorescence spectroscopy. Using PS fluorescence, cell uptake of these particles was confirmed by confocal microscopy and fluorescence-activated cell sorting. PS-dendrimers are more efficient than free PS in PDT-mediated cell death assays in HER2 positive cells, SK-OV-3. Similar effects were absent in HER2 negative cell line, MCF-7. Compared to free PS, the PS-dendrimers have shown significant tumor suppression in a xenograft animal tumor model. Conjugation of a PS with dendrimers and with a targeting agent has enhanced photodynamic therapeutic effects of the PS.Keywords: photodynamic therapy, dendrimers, nanoparticle, targeted delivery, Affibody, xenograft animal model
format article
author Narsireddy A
Vijayashree K
Adimoolam MG
Manorama SV
Rao NM
author_facet Narsireddy A
Vijayashree K
Adimoolam MG
Manorama SV
Rao NM
author_sort Narsireddy A
title Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
title_short Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
title_full Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
title_fullStr Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
title_full_unstemmed Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
title_sort photosensitizer and peptide-conjugated pamam dendrimer for targeted in vivo photodynamic therapy
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/f3efce58317340ebae7f1a0a3945b41e
work_keys_str_mv AT narsireddya photosensitizerandpeptideconjugatedpamamdendrimerfortargetedinvivophotodynamictherapy
AT vijayashreek photosensitizerandpeptideconjugatedpamamdendrimerfortargetedinvivophotodynamictherapy
AT adimoolammg photosensitizerandpeptideconjugatedpamamdendrimerfortargetedinvivophotodynamictherapy
AT manoramasv photosensitizerandpeptideconjugatedpamamdendrimerfortargetedinvivophotodynamictherapy
AT raonm photosensitizerandpeptideconjugatedpamamdendrimerfortargetedinvivophotodynamictherapy
_version_ 1718403292241854464